Evidence map›Paper›PMID 37673914›Full record

ArticleNature communications2023

NAD(H) homeostasis underlies host protection mediated by glycolytic myeloid cells in tuberculosis.

Hayden T Pacl, Krishna C Chinta, Vineel P Reddy, Sajid Nadeem, Ritesh R Sevalkar, Kievershen Nargan, Kapongo Lumamba, Threnesan Naidoo, Joel N Glasgow, Anupam Agarwal and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Hayden T PaclDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID http://orcid.org/0000-0003-2303-6623
Krishna C ChintaDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID http://orcid.org/0000-0001-8425-2456
Vineel P ReddyDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID http://orcid.org/0000-0001-8605-3143
Sajid NadeemDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.
Ritesh R SevalkarDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.
Kievershen NarganAfrica Health Research Institute, University of KwaZulu Natal, Durban, South Africa.
Kapongo LumambaAfrica Health Research Institute, University of KwaZulu Natal, Durban, South Africa.
Threnesan NaidooAfrica Health Research Institute, University of KwaZulu Natal, Durban, South Africa.
Joel N GlasgowDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID http://orcid.org/0000-0002-2842-7917
Anupam AgarwalDepartment of Medicine, Division of Nephrology, Nephrology Research and Training Center, University of Alabama at Birmingham, Birmingham, AL, USA. agarwal@uab.edu.ORCID http://orcid.org/0000-0003-4276-5186
Adrie J C SteynDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA. asteyn@uab.edu.ORCID http://orcid.org/0000-0001-9177-8827
University of Alabama at Birmingham · USAfrica Health Research Institute · ZA

Funding

Construction/SEBLAB/Regional Biocontainment LaboratoryUC6AI058599 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MARCHASE, RICHARD BANFIELD · 2003 to 2006
$22.0M
UAB-UCSD O'Brien Core Center for Acute Kidney Injury ResearchP30DK079337 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI AGARWAL, ANUPAM · 2008 to 2022
$18.3M
Hydrogen Sulfide and Tuberculosis DiseaseR01AI134810 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI STEYN, ADRIE JC · 2018 to 2021
$2.2M
Interplay between the Mtb electron transport chain and carbon metabolismR01AI137043 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI STEYN, ADRIE JC · 2019 to 2023
$2.1M
METABOLIC REPROGRAMMING OF T CELL ENERGY METABOLISM IN TUBERCULOSIS AND HIVR33AI138280 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI STEYN, ADRIE JC · 2020 to 2023
$2.0M
NIAID NIH HHS R01 AI134810NIAID NIH HHS R01 AI137043NIAID NIH HHS R33 AI138280NIAID NIH HHS UC6 AI058599NIDDK NIH HHS P30 DK079337Wellcome Trust
6 · The paper itself

Abstract

Mycobacterium tuberculosis (Mtb) disrupts glycolytic flux in infected myeloid cells through an unclear mechanism. Flux through the glycolytic pathway in myeloid cells is inextricably linked to the availability of NAD

Indexed as

NADTuberculosisAnimalsGlycolysisHomeostasisLactate Dehydrogenase 5MiceMyeloid CellsNiacinamideLactate Dehydrogenase 5NADNiacinamide

Identifiers

PMID37673914
PMCPMC10482943
OpenAlexW4386484862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.